First, six infusions of ketamine associated with increased the levels of leptin and OPG, and decreased the levels of OC, OPN, SOST, PTH and FGF23 in patients with depression, which occurred immediately the day after the last infusion (Day 13) and lasted for 2-week post-infusion (Day 26). The gene discussed is SPP1; the disease is major depressive disorder.